News and Events

Imiquimod Cream a Viable Option for Melanoma In Situ, Lentigo Maligna Type

2 April 2015

Imiquimod cream appears to be a viable option for primary or adjuvant treatment of lentigo maligna (LM) in older patients who are poor surgical candidates, according to authors of a recent retrospective cohort study. A randomized, controlled, prospective trial should be performed to determine the long-term efficacy.

News from the American Academy of Dermatology Conference

26 March 2015

Highlighted presentations at the annual American Academy of Dermatology conference available from Medpage Today include the uncertain status of spray sunscreens, the case for following patients with in-situ melanoma and the value of a single dermatology visit in reducing the odds for diagnosis of invasive melanoma.

Need for Consensus on Sentinel Node Biopsy

24 March 2015

Responding to two articles in the British Journal of Dermatology reflecting "the polarization that bedevils the state of sentinel node biopsy (SNB) in melanoma", an editorial in the same edition calls for a consensus in management to help patients make informed decisions about their treatment.

Skin Damage May Continue After UV Exposure

3 March 2015

Damage caused by ultraviolet (UV) radiation could continue hours after exposure, according to a new laboratory study by US researchers. While it was previously believed that melanin protected the skin from harmful UV light, researchers found that melanin also might have a carcinogenic role.

Text Messages Can Improve Skin Cancer Prevention

2 March 2015

Mobile text messages can improve skin cancer prevention while promoting solar protection, according to the results of a recent collaborative study between QUT, Cancer Council Queensland and University of Queensland published in the journal Preventative Medicine journal. The trial was named the "Healthy Text" and assessed the influence and value of SMS-delivered messages that promoted solar protection and skin self-examination.

"Melanoma Detection" Apps Lack Scientific Support

1 March 2015

Following consumer complaints, the US Federal Trade Commission has challenged claims by marketers of "melanoma detection" apps that these could detect symptoms of melanoma as lacking scientific proof.